Supported by National Institutes of Health (Bethesda, MD, USA) Grants EY-02115 (DCH) and EY-025253 (CGDM).
Disclosure: D.C. Hood, Topcon, Inc. (F, C), Heidelberg Engineering (F, C), Novartis, Inc. (C); E. Tsamis, None; N.K. Bommakanti, None; D.B. Joiner, None; L.A. Al-Aswad, None; D.M. Blumberg, None; G.A. Cioffi, None; J.M. Liebmann, None; C.G. De Moraes, Carl Zeiss Meditec, Inc. (R), Topcon, Inc. (R), Heidelberg Engineering (R), Novartis, Inc. (C), Galimedix, Inc. (C), Lin Biosciences, Inc. (C), Reichert, Inc. (C)